The life settlement market is arguably in a strong position. The 2025 ELSA–Conning Investor Sentiment Study confirms what market participants already sense: over half of investors rated satisfaction at nine or ten out of ten, more than a third plan to increase exposure, and life settlements are increasingly classified within institutional “resilience buckets” alongside private credit and real assets.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet
A new report by reinsurer RGA says that the combination of disease-modifying therapies and better…
EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper
Feedback from the industry is due by the end of April.
Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital
LifeRoc Capital’s Brandon Marz provides his thoughts on the state of the life settlement industry’s…
Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?
Why a different approach might be needed to bring the UK’s secondary life insurance market…
